Defining inflammatory biomarkers in motor neuron disease patients to assist in clinical trial efficiency of the C5aR antagonist PMX205 (2017–2019)

Grant type:
Wesley Medical Research Ltd
Researchers:
Funded by:
Wesley Medical Research Ltd